뒤로
Bristol-Myers Squibb Co(BMY) 가격
BMY 주가 차트
BMY 주가 예측
Bristol-Myers Squibb Co
$54.22
-1.88%
$-1.03
종가: Jan 20, 16:00:00 GMT-5
$54.29
0.12%
$0.07
애프터마켓: Jan 20, 20:00:00 GMT-5
B-
최종 점수
주요 통계
이전 종가
$55.26
시가
$54.53
일일 범위
$53.88 - $54.9
52주 범위
$42.52 - $63.33
거래량
10.7M
평균 거래량
15.4M
EPS(TTM)
2.96
배당수익률
4.59%
시가총액
$110.5B
BMY란 무엇인가요?
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company is headquartered in Princeton, New Jersey and currently employs 34,100 full-time employees. The company is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Opdualag (nivolumab and relatlimab-rmbw), Breyanzi (lisocabtagene maraleucel), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), and Sotyktu (deucravacitinib). Its other growth products include Onureg, Inrebic, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension). Opdivo (nivolumab) is a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells.